| Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links |
20 |
| Sarcopenic obesity |
19 |
| Obesity and bone metabolism |
18 |
| Early life stress and trauma: developmental neuroendocrine aspects of prolonged stress system dysregulation |
16 |
| Sex differences in stress responses: a critical role for corticotropin-releasing factor |
13 |
| Diabetes and lipid metabolism |
13 |
| Perinatal hypoxia as a risk factor for psychopathology later in life: the role of dopamine and neurotrophins |
12 |
| The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD) |
10 |
| SOCS3 as a future target to treat metabolic disorders |
8 |
| Metformin and gut microbiota: their interactions and their impact on diabetes |
8 |
| Vitamin D basis of Alzheimer's disease: from genetics to biomarkers |
8 |
| From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course? |
8 |
| The association between vitamin D status and infectious diseases of the respiratory system in infancy and childhood |
7 |
| Patient empowerment and the Mediterranean diet as a possible tool to tackle prediabetes associated with overweight or obesity: a pilot study |
7 |
| Ga-68-PSMA PET thyroid incidentalomas |
7 |
| Current understanding of the structure and function of family B GPCRs to design novel drugs |
7 |
| Selenoproteins in human body: focus on thyroid pathophysiology |
6 |
| 5-alpha-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review |
6 |
| The role of vitamin D in the pathogenesis and treatment of diabetes mellitus: a narrative review |
6 |
| The relationship between urotensin II and insulin resistance in women with gestational diabetes mellitus |
5 |
| Irritable bowel syndrome: a new therapeutic target when treating obesity? |
5 |
| Guidelines for exercise during normal pregnancy and gestational diabetes: a review of international recommendations |
5 |
| Clinical pharmacology of glucagon-like peptide-1 receptor agonists |
5 |
| Chronic stress and body composition disorders: implications for health and disease |
5 |
| The development of probiotics therapy to obesity: a therapy that has gained considerable momentum |
4 |
| TCF7L2 gene variants predispose to the development of type 2 diabetes mellitus among individuals with metabolic syndrome |
4 |
| Imaging of nonalcoholic fatty liver disease and its clinical utility |
4 |
| The role of cellular senescence in diabetes mellitus and osteoporosis: molecular pathways and potential interventions |
4 |
| Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview |
4 |
| A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins |
3 |
| The role of biphosphonates in the management of thalassemia-induced osteoporosis: a systematic review and meta-analysis |
3 |
| The past decade in type 2 diabetes and future challenges |
3 |
| An update on adrenal endocrinology: significant discoveries in the last 10years and where the field is heading in the next decade |
3 |
| A rare cause of neonatal hypoglycemia in two siblings: TBX19 gene mutation |
3 |
| The low levels of bone morphogenic protein-4 and its antagonist noggin in type 2 diabetes |
2 |
| Review of mobile applications for optimizing the follow-up care of patients with diabetes |
2 |
| Decreased circulating levels of ANGPTL8 in Graves' disease patients |
2 |
| Non-functioning pituitary macroadenoma: surgical outcomes, tumor regrowth, and alterations in pituitary function-3-year experience from the Iranian Pituitary Tumor Registry |
2 |
| Ischemic stroke and select adipose-derived and sex hormones: a review |
2 |
| Subclinical hypothyroidism: new trials, old caveats |
2 |
| A year in type 2 diabetes mellitus: 2018 review based on the Endorama lecture |
2 |
| Endocrine paraneoplastic syndromes in lung cancer |
2 |
| Heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A1) can cause transient adrenal insufficiency and life-threatening failure to thrive |
2 |
| Replenishment of vitamin D status: theoretical and practical considerations |
2 |
| Non-alcoholic fatty liver infiltration in children: an underdiagnosed evolving disease |
2 |
| Decreased adipocyte glucose transporter 4 (GLUT4) and aquaglyceroporin-7 (AQP7) in adults with morbid obesity: possible early markers of metabolic dysfunction |
2 |
| An unsuspicious thyroid nodule with fatal outcome |
2 |
| Perinatal SSRI medications and offspring hippocampal plasticity: interaction with maternal stress and sex |
2 |
| Relationship of lipid regulatory gene polymorphisms and dyslipidemia in a pediatric population: the CASPIAN III study |
2 |
| Localised Langerhans cell histiocytosis of the hypothalamic-pituitary region: case report and literature review |
2 |
